Podcast Episodes
Back to Search
Episode 519: What is the Appropriate Approach to Adjuvant Therapy for UTUC?
Shilpa Gupta joins us to discuss an X poll revealing equipoise about treatment approaches to resected high-risk upper tract urothelial cancer (UTUC).
3 weeks ago
Episode 518: PSMAddition in Clinical Practice
Rob Dreicer joins the show to discuss the FDA approval of Lutetium Lu 177 in the mHSPC space and how to contextualize the benefit/risk
4 weeks ago
Episode 517: Casdatifan Clinical Data in RCC and Translational Correlates
Toni Choueiri joins Brian and Tom to discuss a recent Nature paper regarding the novel HIF inhibitor, casdatifan, and biomarkers of response.
1 month, 3 weeks ago
Episode 516: The Influence of Hypoxia on Response and Resistance in RCC
Ari Hakimi and Lyn Voung from MSKCC join Brian and Tom to discuss their recent Cancer Cell paper exploring the mechanistic impact of TKI-induced hypo…
2 months, 1 week ago
Episode 515: PROTEUS - A Reflection on the Data and Controversies with Neha Vapiwala
Brian and Tom invite Neha Vapiwala, a Radiation Oncologist, to discuss areas of consensus and controversy from the PROTEUS trial of ADT +/- apalutami…
2 months, 3 weeks ago
Episode 514: Artificial Intelligence in Cancer Drug Development
Travis Zack, CMO of Open Evidence, joins Brian and Tom to discuss the emergence of AI across the spectrum on cancer, drug development and application…
3 months ago
Episode 513: Trials and Tribulations of Investigator-initiated Research
Bishoy Faltas joins Brian and Tom to discuss his IIT in bladder cancer. The intended discussion of the trials turned into an insightful discussion on…
3 months, 1 week ago
Episode 512: ENZA-P Nature Medicine translational data
In our final episode recorded at APCCC, Louise Emmett joins us to discuss clinical results and mechanisms of PSMA upregulation by enzalutamide.
3 months, 2 weeks ago
Episode 510: ADCs in Prostate Cancer
Tanya Dorff joins Tom and Brian to discuss her ASCO 2026 data on a novel dual targeting ADC in prostate cancer. The broader scope of ADC development …
4 months, 1 week ago
Episode 509: ASCO 2026 Review
This comprehensive podcast covers the latest advances in prostate, bladder, and kidney cancers from ASCO 2026, including new therapies, trial data, a…
4 months, 2 weeks ago